Venture capital firm Archives - Inside Precision Medicine

Inside Precision Medicine CRISPR-, Macrophage-Focused DEM BioPharma Launches with $70M Financing

Microscopic view of phagocytic macrophages, which are involved in the immune response within the body to conditions such as melanoma skin cancer.

News & Features

CRISPR-, Macrophage-Focused DEM BioPharma Launches with $70M Financing

Chris Anderson -

June 27, 2022

Healthcare Technology

Informatics

AI-Based Drug Discoverer Verge Genomics Raises $32M in Series A Financing

Inside Precision Medicine Staff Writer -

July 16, 2018

Related Content

eGenesis Raises $191 Million for Gene Edited Pig Organs

eGenesis Raises $191 Million for Gene Edited Pig Organs

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice

UCLA Receives $120 Million Gift to Establish the California Institute for Immunology and Immunotherapy

UCLA Receives $120 Million Gift to Establish the California Institute for Immunology and Immunotherapy

Global Trial of BioNTech’s mRNA-Based Lung Cancer Vaccine Launches

Global Trial of BioNTech’s mRNA-Based Lung Cancer Vaccine Launches